Pulmonx Corp (LUNG)

$1.68 -0.10 (-5.62%)
Market Cap 70.96M
Revenue (ttm) 90.50M
Net Income (ttm) -54.00M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -59.67%
Debt to Equity Ratio 0.62
Volume 535,800
Avg Vol 498,752
Day's Range N/A - N/A
Shares Out 42.24M
Stochastic %K 35%
Beta 0.07
Analysts Strong Sell
Price Target $5.17

Company Profile

Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography a...

Industry: Medical Devices
Sector: Healthcare
Phone: 650 364 0400
Website: pulmonx.com
Address:
700 Chesapeake Drive, Redwood City, United States
MAGA1717
MAGA1717 Mar. 14 at 1:08 PM
$LUNG R/S incomin. You have been warned
0 · Reply
beachsidefreddy
beachsidefreddy Mar. 13 at 11:50 PM
$LUNG someone just bought 5000 shares at 1.70
0 · Reply
healthcareguru
healthcareguru Mar. 13 at 7:35 PM
$LUNG Gimme 😍
0 · Reply
beachsidefreddy
beachsidefreddy Mar. 11 at 10:20 PM
$LUNG this is going to rip tomorrow
3 · Reply
beachsidefreddy
beachsidefreddy Mar. 10 at 10:44 PM
$LUNG the fund bought 2.6 million I can assure you knew that tarrif bs
0 · Reply
d_risk
d_risk Mar. 10 at 9:56 PM
$LUNG - Pulmonx Corporation - 10K - Updated Risk Factors LUNG flags heightened cyber and AI-driven attack risks (including shared-responsibility gaps), replaces its CIBC facility with a new Perceptive credit agreement, formalizes resolution of a DOJ-related qui tam, and expands exposure to tariffs, trade policy, privacy, data localization, and DOJ-sensitive data rules. #HealthcareTechnology #CybersecurityRisk #AIThreats #FinancialRestructuring #RegulatoryCompliance 🟢 Added 🟠 Removed https://d-risk.ai/LUNG/10-K/2026-03-10
1 · Reply
beachsidefreddy
beachsidefreddy Mar. 10 at 8:02 PM
$LUNG 3.3 mill short from NASDAQ
0 · Reply
beachsidefreddy
beachsidefreddy Mar. 10 at 6:52 PM
$LUNG can’t wait for short interest at 4 pm
0 · Reply
beachsidefreddy
beachsidefreddy Mar. 9 at 10:13 PM
$LUNG thats 2.6 million shares shorts, 3.2 million, cant get!!!!!!!!! oh boy
0 · Reply
beachsidefreddy
beachsidefreddy Mar. 9 at 9:45 PM
$LUNG MICHAEL DID YOU SEE FILING I JUST POSTED JUST HIT AT 5 pm
0 · Reply
Latest News on LUNG
Pulmonx Corporation (LUNG) Q4 2025 Earnings Call Transcript

Mar 4, 2026, 6:22 PM EST - 10 days ago

Pulmonx Corporation (LUNG) Q4 2025 Earnings Call Transcript

Pulmonx Reports Fourth Quarter and Full Year 2025 Financial Results

Mar 4, 2026, 4:06 PM EST - 10 days ago

Pulmonx Reports Fourth Quarter and Full Year 2025 Financial Results

Pulmonx Announces Closing of up to $60 Million Credit Facility

Mar 4, 2026, 4:05 PM EST - 10 days ago

Pulmonx Announces Closing of up to $60 Million Credit Facility

Pulmonx to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026

Feb 20, 2026, 8:00 AM EST - 23 days ago

Pulmonx to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026

Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Dec 3, 2025, 4:05 PM EST - 3 months ago

Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Pulmonx Corporation (LUNG) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 7:21 PM EST - 4 months ago

Pulmonx Corporation (LUNG) Q3 2025 Earnings Call Transcript

Pulmonx Reports Third Quarter 2025 Financial Results

Nov 12, 2025, 4:05 PM EST - 4 months ago

Pulmonx Reports Third Quarter 2025 Financial Results

Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025

Oct 27, 2025, 4:05 PM EDT - 4 months ago

Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025

Pulmonx to Report Third Quarter 2025 Financial Results on October 29, 2025

Oct 15, 2025, 4:05 PM EDT - 5 months ago

Pulmonx to Report Third Quarter 2025 Financial Results on October 29, 2025

Pulmonx to Participate in September Investor Conferences

Aug 26, 2025, 4:05 PM EDT - 7 months ago

Pulmonx to Participate in September Investor Conferences

Pulmonx Corporation (LUNG) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 10:00 PM EDT - 8 months ago

Pulmonx Corporation (LUNG) Q2 2025 Earnings Call Transcript

Pulmonx Reports Second Quarter 2025 Financial Results

Jul 30, 2025, 4:05 PM EDT - 8 months ago

Pulmonx Reports Second Quarter 2025 Financial Results

Pulmonx to Report Second Quarter 2025 Financial Results on July 30, 2025

Jul 16, 2025, 4:05 PM EDT - 8 months ago

Pulmonx to Report Second Quarter 2025 Financial Results on July 30, 2025

Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

May 28, 2025, 4:05 PM EDT - 10 months ago

Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference

May 1, 2025, 4:05 PM EDT - 11 months ago

Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference

Pulmonx Corporation (LUNG) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 8:25 PM EDT - 11 months ago

Pulmonx Corporation (LUNG) Q1 2025 Earnings Call Transcript

Pulmonx Reports First Quarter 2025 Financial Results

Apr 30, 2025, 4:05 PM EDT - 11 months ago

Pulmonx Reports First Quarter 2025 Financial Results

EDAP Appoints Glen French to Board of Directors

Mar 3, 2025, 7:00 AM EST - 1 year ago

EDAP Appoints Glen French to Board of Directors

EDAP

Top 3 Health Care Stocks You May Want To Dump In February

Feb 20, 2025, 3:50 PM EST - 1 year ago

Top 3 Health Care Stocks You May Want To Dump In February

MD SWTX

Pulmonx Corporation (LUNG) Q4 2024 Earnings Call Transcript

Feb 19, 2025, 7:40 PM EST - 1 year ago

Pulmonx Corporation (LUNG) Q4 2024 Earnings Call Transcript

Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results

Feb 19, 2025, 4:05 PM EST - 1 year ago

Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results

Pulmonx to Present at the Citi 2025 Unplugged Medtech and Life Sciences Access Day

Feb 13, 2025, 4:05 PM EST - 1 year ago

Pulmonx to Present at the Citi 2025 Unplugged Medtech and Life Sciences Access Day

Pulmonx to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025

Feb 5, 2025, 4:05 PM EST - 1 year ago

Pulmonx to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025

Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference

Nov 20, 2024, 4:05 PM EST - 1 year ago

Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference

Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers

Nov 19, 2024, 9:00 AM EST - 1 year ago

Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers

Pulmonx to Present at the Stifel 2024 Healthcare Conference

Nov 5, 2024, 4:05 PM EST - 1 year ago

Pulmonx to Present at the Stifel 2024 Healthcare Conference

Pulmonx Corporation (LUNG) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 6:54 AM EDT - 1 year ago

Pulmonx Corporation (LUNG) Q3 2024 Earnings Call Transcript

Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024

Oct 16, 2024, 4:05 PM EDT - 1 year ago

Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024

Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024

Sep 9, 2024, 4:05 PM EDT - 1 year ago

Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024

Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference

Aug 29, 2024, 4:05 PM EDT - 1 year ago

Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference

Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference

Aug 22, 2024, 4:05 PM EDT - 1 year ago

Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference

Pulmonx Corporation (LUNG) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 10:33 PM EDT - 1 year ago

Pulmonx Corporation (LUNG) Q2 2024 Earnings Call Transcript

Pulmonx Reports Second Quarter 2024 Financial Results

Jul 31, 2024, 4:05 PM EDT - 1 year ago

Pulmonx Reports Second Quarter 2024 Financial Results

Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference

Jul 29, 2024, 4:05 PM EDT - 1 year ago

Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference

Pulmonx: Low Bar For Q2 Earnings

Jul 21, 2024, 9:00 AM EDT - 1 year ago

Pulmonx: Low Bar For Q2 Earnings

Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024

Jul 10, 2024, 4:05 PM EDT - 1 year ago

Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024

Pulmonx Corporation (LUNG) Q1 2024 Earnings Call Transcript

May 1, 2024, 9:08 PM EDT - 2 years ago

Pulmonx Corporation (LUNG) Q1 2024 Earnings Call Transcript

Pulmonx Reports First Quarter 2024 Financial Results

May 1, 2024, 4:05 PM EDT - 2 years ago

Pulmonx Reports First Quarter 2024 Financial Results

Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024

Apr 10, 2024, 4:05 PM EDT - 2 years ago

Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024

Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer

Apr 2, 2024, 4:05 PM EDT - 2 years ago

Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer

Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial

Feb 26, 2024, 8:00 AM EST - 2 years ago

Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial

Pulmonx Corporation (LUNG) Q4 2023 Earnings Call Transcript

Feb 21, 2024, 9:01 PM EST - 2 years ago

Pulmonx Corporation (LUNG) Q4 2023 Earnings Call Transcript

Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 21, 2024, 4:06 PM EST - 2 years ago

Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results

Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer

Feb 21, 2024, 4:05 PM EST - 2 years ago

Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer

Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024

Feb 7, 2024, 4:05 PM EST - 2 years ago

Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024

Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference

Nov 15, 2023, 4:05 PM EST - 2 years ago

Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference

The Prognosis For Pulmonx Corporation

Nov 8, 2023, 12:01 PM EST - 2 years ago

The Prognosis For Pulmonx Corporation

Pulmonx to Participate at Upcoming Investor Conferences

Oct 31, 2023, 4:05 PM EDT - 2 years ago

Pulmonx to Participate at Upcoming Investor Conferences

Pulmonx Corporation (LUNG) Q3 2023 Earnings Call Transcript

Oct 30, 2023, 8:37 PM EDT - 2 years ago

Pulmonx Corporation (LUNG) Q3 2023 Earnings Call Transcript

Pulmonx Reports Record Third Quarter 2023 Financial Results

Oct 30, 2023, 4:05 PM EDT - 2 years ago

Pulmonx Reports Record Third Quarter 2023 Financial Results

MAGA1717
MAGA1717 Mar. 14 at 1:08 PM
$LUNG R/S incomin. You have been warned
0 · Reply
beachsidefreddy
beachsidefreddy Mar. 13 at 11:50 PM
$LUNG someone just bought 5000 shares at 1.70
0 · Reply
healthcareguru
healthcareguru Mar. 13 at 7:35 PM
$LUNG Gimme 😍
0 · Reply
beachsidefreddy
beachsidefreddy Mar. 11 at 10:20 PM
$LUNG this is going to rip tomorrow
3 · Reply
beachsidefreddy
beachsidefreddy Mar. 10 at 10:44 PM
$LUNG the fund bought 2.6 million I can assure you knew that tarrif bs
0 · Reply
d_risk
d_risk Mar. 10 at 9:56 PM
$LUNG - Pulmonx Corporation - 10K - Updated Risk Factors LUNG flags heightened cyber and AI-driven attack risks (including shared-responsibility gaps), replaces its CIBC facility with a new Perceptive credit agreement, formalizes resolution of a DOJ-related qui tam, and expands exposure to tariffs, trade policy, privacy, data localization, and DOJ-sensitive data rules. #HealthcareTechnology #CybersecurityRisk #AIThreats #FinancialRestructuring #RegulatoryCompliance 🟢 Added 🟠 Removed https://d-risk.ai/LUNG/10-K/2026-03-10
1 · Reply
beachsidefreddy
beachsidefreddy Mar. 10 at 8:02 PM
$LUNG 3.3 mill short from NASDAQ
0 · Reply
beachsidefreddy
beachsidefreddy Mar. 10 at 6:52 PM
$LUNG can’t wait for short interest at 4 pm
0 · Reply
beachsidefreddy
beachsidefreddy Mar. 9 at 10:13 PM
$LUNG thats 2.6 million shares shorts, 3.2 million, cant get!!!!!!!!! oh boy
0 · Reply
beachsidefreddy
beachsidefreddy Mar. 9 at 9:45 PM
$LUNG MICHAEL DID YOU SEE FILING I JUST POSTED JUST HIT AT 5 pm
0 · Reply
beachsidefreddy
beachsidefreddy Mar. 9 at 9:21 PM
$LUNG https://archive.fast-edgar.com/20260309/AL2ZD22CLM22525L222W2MY2STEJZ222Z682/ !!!!!!!!!!!!! hold on!!
0 · Reply
beachsidefreddy
beachsidefreddy Mar. 9 at 8:12 PM
$LUNG and again I ask why is Goldman .Sachs in $1.80 stock on box?
0 · Reply
beachsidefreddy
beachsidefreddy Mar. 9 at 8:11 PM
$LUNG that was the most contrived trading day I have seen and I’ve been in the stock looking for six months
0 · Reply
ThickStripe
ThickStripe Mar. 9 at 8:02 PM
$LUNG Insider / employee buying last week and getting trapped. Product fit is terrible for any Acquistion and reimbursement is not substantial for hospitals to build programs.
1 · Reply
beachsidefreddy
beachsidefreddy Mar. 9 at 6:32 PM
$LUNG. HIGHEST
0 · Reply
beachsidefreddy
beachsidefreddy Mar. 9 at 5:11 PM
$LUNG they are determined to try to keep this down today, but the shorts have returned the most that I’ve seen since I owned it so something has to give
0 · Reply
beachsidefreddy
beachsidefreddy Mar. 9 at 4:51 PM
$LUNG Be ready
0 · Reply
MAGA1717
MAGA1717 Mar. 9 at 3:46 PM
$LUNG poor guidance and insiders dumping. Sub $1 incoming
1 · Reply
MAGA1717
MAGA1717 Mar. 9 at 2:23 PM
$LUNG easiest short ever #teammagastrikesagain
0 · Reply
healthcareguru
healthcareguru Mar. 9 at 2:08 PM
$LUNG what moron is selling a massive 10x bagger brewing?!?! Inflection & turnaround story is fully underway… $15 PT. 😍🦾
1 · Reply
beachsidefreddy
beachsidefreddy Mar. 9 at 1:46 PM
$LUNG lol!!! Stock will be up on day
1 · Reply
octavia8
octavia8 Mar. 9 at 12:34 PM
$LUNG why are we going down
1 · Reply